E-Book, Englisch, 333 Seiten
Lin / Zhao Handbook on Analyzing Human Genetic Data
1. Auflage 2009
ISBN: 978-3-540-69264-5
Verlag: Springer-Verlag
Format: PDF
Kopierschutz: Adobe DRM (»Systemvoraussetzungen)
Computational Approaches and Software
E-Book, Englisch, 333 Seiten
ISBN: 978-3-540-69264-5
Verlag: Springer-Verlag
Format: PDF
Kopierschutz: Adobe DRM (»Systemvoraussetzungen)
Autoren/Hrsg.
Weitere Infos & Material
1;Preface and Introduction;5
2;Contents;10
3;Population Genetics;14
3.1;1 Introduction;14
3.2;2 Within-Population Analyses;15
3.2.1;2.1 Genotype and Allele Frequencies;15
3.2.2;2.2 Maximum Likelihood Estimation;16
3.2.3;2.3 Inbreeding Coefficient;17
3.2.4;2.4 Testing for Hardy–Weinberg Equilibrium;19
3.2.5;2.5 Linkage Disequilibrium;21
3.2.6;2.6 Composite Linkage Disequilibrium;22
3.2.7;2.7 Testing for Linkage Equilibrium;23
3.2.8;2.8 Application to Data;24
3.3;3 Between-Population and Analyses;29
3.3.1;3.1 F-statistics;29
3.3.2;3.2 Application to Data;33
3.4;4 Discussion;35
3.5;5 Web Resources;35
3.6;References;36
4;Haplotype Structure;37
4.1;1 Population Haplotype Structure;37
4.1.1;1.1 Haplotype Block Structure in Human Populations;37
4.1.2;1.2 Wright–Fisher Model;38
4.1.3;1.3 Coalescent Theory;40
4.2;2 Public Genotype/Haplotype Databases;42
4.2.1;2.1 International HapMap Project;43
4.2.1.1;Download Genotype Data from HapMap;44
4.2.2;2.2 The HapMap ENCODE Resequencingand Genotyping Project;45
4.2.2.1;2.2.1 Download ENCODE Genotype Data;46
4.2.3;2.3 Haplotype Simulation;46
4.3;3 Haploview;48
4.3.1;3.1 What is Haploview?;48
4.3.2;3.2 How to Download and Install Haploview;48
4.3.3;3.3 How to Run Haploview;49
4.3.3.1;3.3.1 How to Use HapMap Data in Haploview;49
4.3.3.2;3.3.2 How to Use Non-HapMap Genotype Data in Haploview;50
4.4;4 Haplotype Inference Methods;53
4.4.1;4.1 Clark's Algorithm;54
4.4.1.1;4.1.1 Software Usage;55
4.4.2;4.2 PHASE;58
4.4.2.1;4.2.1 PHASE Algorithm;59
4.4.2.2;4.2.2 Software Usage;60
4.4.3;4.3 HAPLOTYPER;65
4.4.3.1;4.3.1 Bayesian Model;65
4.4.3.2;4.3.2 Partition–Ligation (PL);66
4.4.3.3;4.3.3 Software Usage;68
4.4.4;4.4 CHB;70
4.4.4.1;4.4.1 CHB Model;70
4.4.4.2;4.4.2 MCMC Sampling and Convergence;72
4.4.4.3;4.4.3 Software Usage;73
4.4.5;4.5 Comparison of Phasing Results;76
4.5;5 Estimation of Recombination Rate;76
4.5.1;5.1 LDhat;77
4.5.1.1;5.1.1 Composite Likelihood Estimation of ;77
4.5.1.2;5.1.2 Likelihood Permutation Test;78
4.5.1.3;5.1.3 Software Usage;79
4.5.2;5.2 HOTSPOTTER;83
4.5.2.1;5.2.1 PAC Model;83
4.5.2.2;5.2.2 Computing the Conditional Distribution ;85
4.5.2.3;5.2.3 Software Usage;86
4.6;Summary;88
4.7;Web Resources;89
4.8;References;89
5;Linkage Analysis of Qualitative Traits;92
5.1;1 Introduction;92
5.2;2 Model-Based Linkage Analysis;93
5.2.1;2.1 Phase-Known Pedigrees;93
5.2.2;2.2 Phase-Unknown Pedigrees;96
5.2.3;2.3 Linkage Analysis in General Case;98
5.2.4;2.4 Elston–Stewart Algorithm;99
5.3;3 Model-Free Linkage Analysis;101
5.3.1;3.1 Fundamental Principle of Model-Free Linkage Analysis;101
5.3.2;3.2 Measure of Genetic Similarity;102
5.3.3;3.3 Model-Free Linkage Analysis for Affected Sib Pairs;103
5.3.4;3.4 Multipoint Analysis for Affected Sib Pairs;106
5.3.5;3.5 Model-Free Linkage Analysis for General Pedigrees;108
5.3.5.1;3.5.1 Inheritance Vector;108
5.3.5.2;3.5.2 NPL Score When the Inheritance Vector Is Known;109
5.3.5.3;3.5.3 NPL Score When the Inheritance Vector Is Uncertain;110
5.3.6;3.6 Lander–Green Algorithm;111
5.4;4 Practical Examples;113
5.5;5 Identifying SNPs Responsible for a Linkage Signal;117
5.5.1;5.1 Assumptions and Definitions;117
5.5.2;5.2 Conditional Probability of Marker Data Given ASP;118
5.5.3;5.3 Relationship Between Disease Locus and Candidate SNP;119
5.5.4;5.4 Hypothesis Testing;120
5.5.5;5.5 Extension to Sibship Data and Nuclear Families;122
5.5.6;5.6 Summary;124
5.6;6 Comparison of Model-Based and Model-Free Linkage Analysis Methods;124
5.6.1;6.1 Software Packages for Linkage Analysis;126
5.7;Web Resources;126
5.8;References;127
6;Linkage Analysis of Quantitative Traits;130
6.1;1 Introduction and Description of Data;130
6.2;2 Methods;132
6.2.1;2.1 Classical Model-Based Linkage Analysis;134
6.2.2;2.2 Model-Free Haseman–Elston Regression Approach;138
6.2.3;2.3 Variance-Components Approaches;139
6.2.4;2.4 Model-Free Variance Regression;145
6.2.5;2.5 Multivariate Models;147
6.2.6;2.6 Joint Linkage and Association Analysis;149
6.3;3 Discussion;149
6.4;4 Web Resources;151
6.5;References;152
7;Markov Chain Monte Carlo Linkage Analysis Methods;157
7.1;1 Introduction;157
7.2;2 Test Data;159
7.2.1;2.1 Data from the Framingham study;159
7.2.2;2.2 Simulated data;160
7.3;3 MCMC Methods and Packages;161
7.4;4 Comparison of Methods;162
7.4.1;4.1 Analysis Strategies;162
7.4.1.1;4.1.1 Estimation of Segregation Models for TH;163
7.4.1.2;4.1.2 Linkage Analysis Based on Loki;164
7.4.1.3;4.1.3 Linkage Analysis Based on MORGAN;164
7.4.1.4;4.1.4 Linkage Analysis Based on SimWalk2;164
7.4.2;4.2 Comparison of the Three Linkage Analysis Software;165
7.4.2.1;4.2.1 Framingham Data;165
7.4.2.2;4.2.2 Simulated Data;169
7.5;5 Conclusions, Recommendations, and Other Considerations;173
7.6;6 Web Resources;177
7.7;References;177
8;Population-Based Association Studies;180
8.1;1 Introduction;180
8.2;2 The Data;181
8.2.1;2.1 Association of a Genetic Marker and a Disease;182
8.2.2;2.2 Testing for Association When No PopulationStratification Is Present;184
8.2.3;2.3 False Positive Can Be Aroused When PopulationStratification Is Present;186
8.3;3 Genome-Control Approach;186
8.4;4 Structured Association Approach;187
8.5;5 Methods Based on Principal Components (PC);189
8.5.1;5.1 Mixture Model;190
8.5.2;5.2 Semi-Parametric Approach;192
8.5.3;5.3 Linear Model Approach;194
8.6;6 Discussion;195
8.7;Web Resources;196
8.8;References;197
9;Family-Based Association Studies;200
9.1;1 Introduction;201
9.2;2 Basic Notations;202
9.3;3 Qualitative Traits, Trios, Bi-Allelic Markers;203
9.3.1;3.1 Qualitative Traits, Trios, Multi-Allelic Markers;204
9.4;4 Family with Multiple Siblings;207
9.5;5 Families with Missing Parental Genotypes;210
9.6;6 Quantitative Phenotypes;217
9.7;7 Joint Analysis of Multiple Markers;221
9.8;8 Other Association Methods Using Family-Based Designs;228
9.8.1;8.1 General Pedigrees;228
9.8.2;8.2 Gene–Gene (GG) interaction and Gene–Environment (GE) Interaction;230
9.9;9 Software Packages and Power Consideration;231
9.10;10 Discussion;236
9.11;References;240
10;Haplotype Association Analysis;250
10.1;1 Introduction;250
10.1.1;1.1 The FUSION Study;252
10.1.2;1.2 General Notation;253
10.2;2 Haplotype Analysis of Unrelated Samples;253
10.2.1;2.1 Cross-Sectional Studies;253
10.2.1.1;2.1.1 Analyses Using Phased Haplotypes;253
10.2.1.2;2.1.2 Analyses Using Unphased Haplotypes;255
10.2.1.3;2.1.3 Stability Issues in Haplotype Analysis;256
10.2.1.4;2.1.4 Modeling Interaction Effects;257
10.2.1.5;2.1.5 Haplotype Clustering;257
10.2.1.6;2.1.6 Software Packages;259
10.2.1.7;2.1.7 Software Application to FUSION Data;261
10.2.2;2.2 Cohort Studies;263
10.2.2.1;2.2.1 Software Packages;264
10.2.3;2.3 Case–Control Studies;264
10.2.3.1;2.3.1 Related Study Designs;267
10.2.3.2;2.3.2 Haplotype Similarity Analyses;268
10.2.3.3;2.3.3 Software Packages;270
10.2.3.4;2.3.4 Software Application to FUSION Data;271
10.3;3 Haplotype Analysis of Family-based Samples;273
10.3.1;3.1 Haplotype Approach of Horvath et al. ;274
10.3.2;3.2 Haplotype Approach of Allen and Satten ;276
10.3.3;3.3 Software Packages;279
10.4;4 Summary;280
10.5;Electronic-Database Information;281
10.6;References;282
11;Multiple Comparisons/Testing Issues;286
11.1;1 Introduction;286
11.2;2 Bonferroni Correction;287
11.3;3 False Discovery Rate;288
11.4;4 Randomization Testing;289
11.5;5 Single Experiment-Wise Test Statistic;291
11.6;6 Example Dataset: Parkinson Disease;292
11.7;7 Discussion;294
11.8;Web Resources;295
11.9;References;295
12;Estimating the Absolute Risk of Disease Associated with Identified Mutations;297
12.1;1 Introduction;297
12.2;2 Population-Based Cohort Studies;300
12.3;3 Case–Control Designs;302
12.4;4 Case–Control Family Study Design;303
12.5;5 Kin–Cohort Design;308
12.6;6 Discussion;312
12.7;References;312
13;Processing Large-Scale, High-Dimension Genetic and Gene Expression Data;314
13.1;1 Introduction;314
13.2;2 Data Management, Access and Workflow;316
13.3;3 Analysis Issues with High-Dimensional Data;318
13.3.1;3.1 Power;318
13.3.2;3.2 Data Trends and Unaccounted for Heterogeneity;320
13.3.3;3.3 Outliers and Transformations;320
13.4;4 Implementing a Standard First-Pass Analysis Pipeline;321
13.4.1;4.1 The Model – Common vs. Individual;321
13.4.2;4.2 Estimating Heritability;322
13.4.3;4.3 Ethnicity and Substructure;323
13.4.4;4.4 Multiplicity;323
13.5;5 High-Performance Computing;324
13.6;6 Further Recommendations for Efficiency Gainsin GOGE Studies;326
13.7;7 Constructing Gene Networks to Enhance GWASand GOGE Results;327
13.7.1;7.1 Constructing Weighted and UnweightedCo-Expression Networks;328
13.7.2;7.2 Using Genetics in Constructing Co-Expression Networks;329
13.7.3;7.3 Identifying Modules of Highly Interconnected Genes in Co-Expression Networks;329
13.8;8 Looking Toward the Future: Probabilistic Causal Networks;331
13.9;9 Summary;332
13.10;Web Resources;333
13.11;References;334
14;Index;338




